高级搜索

应用反义TGF-β1 基因进行骨肉瘤免疫基因治疗的研究

Study on the Immunogenic Therapy for Osteosarcoma by Antisense TGF-β1 Gene

  • 摘要: 目的 探讨反义转化生长因子β1基因治疗骨肉瘤的价值. 方法 用转基因技术将反义转化生长因子基因导入骨肉瘤细胞LM8,构建转基因细胞株.用骨肉瘤细胞株LM8皮下注射C3H雄性小鼠建立小鼠骨肉瘤移植瘤模型.应用灭活的转基因骨肉瘤细胞、灭活的未转基因骨肉瘤细胞分原位和异位进行治疗. 结果 两种治疗措施都可表现出一定程度的抑瘤作用,其中以灭活的转基因骨肉瘤细胞治疗效果最佳,原位治疗效果优于异位治疗. 结 论灭活的骨肉瘤细胞也有一定的免疫治疗作用;反义转化生长因子基因对小鼠移植性骨肉瘤有较好的实验治疗效果,为人骨肉瘤进行反义转化生长因子基因治疗提供了一定的依据.

     

    Abstract: Objective  To investigation the effects of the treatment on the osteosarcoma by antisense TGF-β1 gene in vivo. Methods  LM8 were transfected with antisense TGF-β1 gene through lipofectamine vector and selected by G418. The model of osteosarcoma was established by C3h mice which were inoculated with LM8 lines. The model tumor was treated by inactivated t ransduced and untransduced LM8 by way of original site and different site, and the treatment of PBS was applied in the group of comparison. Results  The significant therapeutic effects was achieved by the treatment of the inactivated transduced LM8. The strong inhibition to generation rate and growth speed was exhibited. A better antitumor effect was achieved in the original site tumor compared with the different site. Conclusion  The way of gene therapy for osteosarcoma by antisense TGF-β1 gene was feasible and effective, which provided the foundation of gene therapy for human osteosarcma.

     

/

返回文章
返回